8-K filing — TELA Bio, Inc. (TELA)
Filed: 2026-08-10 AccNo: 0001104659-26-093371 Size: 294 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Read original at edgarStocks · News reference
TELA Bio shares are trading lower after the company reported worse-than-expected Q2 financial results.
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 11, 2026, 6:15 PM
- Checked
- Aug 11, 2026, 6:15 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
TELA Bio Q2 EPS $(0.20) Misses $(0.18) Estimate, Sales $19.291M Miss $20.008M Estimate
TELA Bio (NASDAQ:TELA) reported quarterly losses of $(0.20) per share which missed the analyst consensus estimate of $(0.18) by 11.11 percent. This is a 9.09 percent increase over losses of $(0.22) per share from the
Read original at benzingaTELA Bio shares are trading higher after the company announced the appointment of Heather Getz as its Chief Executive Officer and Director.
Read original at benzinga